so “it’s too expensive with a failure CEO” but if it was cheaper then it would be ok to buy with the same “failure CEO” still running it.
maybe you want to reconsider your thought process here as doesn’t sound very logically imo
- Forums
- ASX - By Stock
- A2M
- High Risk Warning
High Risk Warning, page-80
-
-
- There are more pages in this discussion • 36 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add A2M (ASX) to my watchlist
|
|||||
Last
$6.85 |
Change
-0.030(0.44%) |
Mkt cap ! $4.952B |
Open | High | Low | Value | Volume |
$6.93 | $6.98 | $6.83 | $10.27M | 1.490M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
7 | 18844 | $6.84 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$6.85 | 41602 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 33 | 6.960 |
1 | 17 | 6.880 |
2 | 575 | 6.810 |
1 | 200 | 6.800 |
2 | 9844 | 6.750 |
Price($) | Vol. | No. |
---|---|---|
6.550 | 46 | 3 |
6.610 | 5064 | 1 |
6.750 | 1413 | 3 |
6.810 | 500 | 1 |
6.820 | 100 | 1 |
Last trade - 16.10pm 15/07/2024 (20 minute delay) ? |
Featured News
A2M (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online